Zenon is leading the B-Cell Technology Team at AstraZeneca in Cambridge. His team is specializing in antibody discovery using single-cell technologies. His work focuses on integrating wet lab and in silico approaches to accelerate therapeutic antibody lead generation. Zenon's research encompasses optimizing immunization strategies, developing automated high-throughput workflows, and applying computational methods to analyze B-cell repertoires for identifying high-quality antibody candidates.